Traditional and Novel Cardiometabolic Risk Markers Across Strata of Body Mass Index in Young Adults

Overview

Journal Obes Sci Pract

Date 2021 Dec 8

PMID 34877012

Citations 4

Authors

Mia Klinkvort Kempel

Trine Nohr Winding

Vibeke Lynggaard

Steven Brantlov

Johan Hviid Andersen

Morten Bottcher

Affiliations

Soon will be listed here.

Abstract

Background: Cardiometabolic risk increases with increasing body mass index (BMI). The exact mechanism is poorly understood, and traditional risk assessment of young adults with obesity has shown to be ineffective. Greater knowledge about potential new effective biomarkers and the use of advanced cardiac imaging for risk assessment in young adults is, therefore, necessary.

Objective: This study aims to explore traditional and novel cardiometabolic risk markers across strata of BMI in young adults.

Methods: Participants ( = 264, 50% women, age 28-30 years) were invited from an ongoing cohort study, based on BMI and sex. BMI-strata were: BMI <25, 25-30, >30 kg/m, representing normal weight (NW), overweight (OW), and obesity (OB). Participants underwent cardiac computed tomography to detect coronary artery calcification, measures of body composition, blood pressure measurements, and a comprehensive panel of circulating cardiometabolic risk markers.

Results: No significant coronary artery calcifications were detected in this study. Minor differences in median levels of traditional risk markers were detected across BMI-strata, for example, total cholesterol (men- NW: 4.7 (4.3-5.1) and OB: 4.8 (4.2-5.6) mmol/L, = 0.58; women- NW: 4.3 (3.9-4.8) and OB: 4.7 (4.2-5.3) mmol/L, = 0.016), whereas substantial differences were seen in markers of inflammation and glucose metabolism, for example, high sensitive CRP (men- NW: 0.6 (0.3-1.1) and OB: 2.8 (1.5-4.0) mg/L, < 0.001; women- NW: 0.7 (0.3-1.7) and OB: 4.0 (2.2-7.8) mg/L, < 0.001) and insulin (men- NW: 47.0 (35.0-59.0) and OB: 113.5 (72.0-151.0) pmol/L, < 0.001; women- NW: 44.0 (35.0-60.0) and OB: 84.5 (60.0-126.0) pmol/L, < 0.001).

Conclusion: In young adults, obesity is associated with an early onset insulin resistance and inflammatory response prior to development of coronary artery calcification and deterioration of lipid profiles.

Citing Articles

Childhood socioeconomic position and cardiometabolic risk in young adulthood- the impact of mental health.

Kempel M, Winding T, Bottcher M, Hansen S, Andersen J BMC Public Health. 2023; 23(1):1136.

PMID: 37312084 PMC: 10265760. DOI: 10.1186/s12889-023-15942-y.

Body Mass Index Is Independently Associated with the Presence of Ischemia in Myocardial Perfusion Imaging.

Sioka C, Zotou P, Papafaklis M, Bechlioulis A, Sakellariou K, Rammos A Medicina (Kaunas). 2022; 58(8).

PMID: 35893102 PMC: 9332284. DOI: 10.3390/medicina58080987.

Evaluating the association between socioeconomic position and cardiometabolic risk markers in young adulthood by different life course models.

Kempel M, Winding T, Bottcher M, Andersen J BMC Public Health. 2022; 22(1):694.

PMID: 35397504 PMC: 8994289. DOI: 10.1186/s12889-022-13158-0.

Traditional and novel cardiometabolic risk markers across strata of body mass index in young adults.

Kempel M, Winding T, Lynggaard V, Brantlov S, Andersen J, Bottcher M Obes Sci Pract. 2021; 7(6):727-737.

PMID: 34877012 PMC: 8633932. DOI: 10.1002/osp4.528.

References

Jensen J, Dardari Z, Blaha M, White S, Shaw L, Rumberger J . Association of Body Mass Index With Coronary Artery Calcium and Subsequent Cardiovascular Mortality: The Coronary Artery Calcium Consortium. Circ Cardiovasc Imaging. 2020; 13(7):e009495. PMC: 7398452. DOI: 10.1161/CIRCIMAGING.119.009495. View

Davis P, Dawson J, RILEY W, Lauer R . Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study. Circulation. 2001; 104(23):2815-9. DOI: 10.1161/hc4601.099486. View

Haffner S . The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol. 2006; 97(2A):3A-11A. DOI: 10.1016/j.amjcard.2005.11.010. View

Berger J, Jordan C, Lloyd-Jones D, Blumenthal R . Screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol. 2010; 55(12):1169-1177. DOI: 10.1016/j.jacc.2009.09.066. View

Winding T, Andersen J, Labriola M, Nohr E . Initial non-participation and loss to follow-up in a Danish youth cohort: implications for relative risk estimates. J Epidemiol Community Health. 2013; 68(2):137-44. DOI: 10.1136/jech-2013-202707. View

Hoogeveen R, Belo Pereira J, Nurmohamed N, Zampoleri V, Bom M, Baragetti A . Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention. Eur Heart J. 2020; 41(41):3998-4007. PMC: 7672529. DOI: 10.1093/eurheartj/ehaa648. View

Ross R . Atherosclerosis--an inflammatory disease. N Engl J Med. 1999; 340(2):115-26. DOI: 10.1056/NEJM199901143400207. View

Poulsen P, Biering K, Winding T, Nohr E, Andersen J . How does childhood socioeconomic position affect overweight and obesity in adolescence and early adulthood: a longitudinal study. BMC Obes. 2018; 5:34. PMC: 6276194. DOI: 10.1186/s40608-018-0210-8. View

Kempel M, Winding T, Lynggaard V, Brantlov S, Andersen J, Bottcher M . Traditional and novel cardiometabolic risk markers across strata of body mass index in young adults. Obes Sci Pract. 2021; 7(6):727-737. PMC: 8633932. DOI: 10.1002/osp4.528. View

10.

Hansson G . Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352(16):1685-95. DOI: 10.1056/NEJMra043430. View

11.

Kumari R, Kumar S, Kant R . An update on metabolic syndrome: Metabolic risk markers and adipokines in the development of metabolic syndrome. Diabetes Metab Syndr. 2019; 13(4):2409-2417. DOI: 10.1016/j.dsx.2019.06.005. View

12.

Andersson C, Vasan R . Epidemiology of cardiovascular disease in young individuals. Nat Rev Cardiol. 2017; 15(4):230-240. DOI: 10.1038/nrcardio.2017.154. View

13.

Miedema M, Dardari Z, Nasir K, Blankstein R, Knickelbine T, Oberembt S . Association of Coronary Artery Calcium With Long-term, Cause-Specific Mortality Among Young Adults. JAMA Netw Open. 2019; 2(7):e197440. PMC: 6646982. DOI: 10.1001/jamanetworkopen.2019.7440. View

14.

Reis Geovanini G, Libby P . Atherosclerosis and inflammation: overview and updates. Clin Sci (Lond). 2018; 132(12):1243-1252. DOI: 10.1042/CS20180306. View

15.

Hales C, Carroll M, Fryar C, Ogden C . Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018. NCHS Data Brief. 2020; (360):1-8. View

16.

Berry J, Lloyd-Jones D, Garside D, Greenland P . Framingham risk score and prediction of coronary heart disease death in young men. Am Heart J. 2007; 154(1):80-6. PMC: 2279177. DOI: 10.1016/j.ahj.2007.03.042. View

17.

Kalaoja M, Corbin L, Tan V, Ahola-Olli A, Havulinna A, Santalahti K . The Role of Inflammatory Cytokines as Intermediates in the Pathway from Increased Adiposity to Disease. Obesity (Silver Spring). 2021; 29(2):428-437. PMC: 8614117. DOI: 10.1002/oby.23060. View

18.

Raggi P, Genest J, Giles J, Rayner K, Dwivedi G, Beanlands R . Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis. 2018; 276:98-108. DOI: 10.1016/j.atherosclerosis.2018.07.014. View

19.

Ridker P, Danielson E, Fonseca F, Genest J, Gotto Jr A, Kastelein J . Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008; 359(21):2195-207. DOI: 10.1056/NEJMoa0807646. View

20.

Mahoney L, Burns T, Stanford W, Thompson B, Witt J, Rost C . Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. J Am Coll Cardiol. 1996; 27(2):277-84. DOI: 10.1016/0735-1097(95)00461-0. View